Search Results - "Da Costa Neves, Patrícia Cristina"
-
1
Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer
Published in Pharmaceutics (16-12-2019)“…Both aptamers and siRNA technologies have now reached maturity, and both have been validated with a product in the market. However, although pegaptanib reached…”
Get full text
Journal Article -
2
Activation of an Effective Immune Response after Yellow Fever Vaccination Is Associated with the Genetic Background and Early Response of IFN-γ and CLEC5A
Published in Viruses (12-01-2021)“…The yellow fever vaccine (YF17DD) is highly effective with a single injection conferring protection for at least 10 years. The YF17DD induces polyvalent…”
Get full text
Journal Article -
3
Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi
Published in PloS one (19-03-2013)“…Chagas' disease is a major public health problem affecting nearly 10 million in Latin America. Despite several experimental vaccines have shown to be…”
Get full text
Journal Article -
4
Decidual production of interferon lambda in response to ZIKV persistence: Clinical evidence and in vitro modelling
Published in Heliyon (15-05-2024)“…Zika virus (ZIKV) infections during pregnancy can result in Congenital Zika Syndrome (CZS), a range of severe neurological outcomes in fetuses that primarily…”
Get full text
Journal Article -
5
TLR expression and NK cell activation after human yellow fever vaccination
Published in Vaccine (18-09-2009)“…Abstract The yellow fever vaccine is very effective with a single injection conferring protection for at least 10 years. Recent evidence suggests that the…”
Get full text
Journal Article -
6
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries
Published in Memórias do Instituto Oswaldo Cruz (01-01-2022)“…Laboratory animals are essential mainly for experiments aiming to study pathogenesis and evaluate antivirals and vaccines against emerging human infectious…”
Get full text
Journal Article -
7
Initial development of biosimilar immune checkpoint blockers using HEK293 cells
Published in Protein expression and purification (01-06-2020)“…Antibodies that block interaction of immune checkpoint receptors with its ligands have revolutionized the treatment of several cancers. Despite the success of…”
Get full text
Journal Article -
8
Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model
Published in Frontiers in immunology (19-06-2024)“…In the Americas, is the predominant causative species of malaria, a debilitating and economically significant disease. Due to the complexity of the malaria…”
Get full text
Journal Article -
9
Identification and validation of specific B-cell epitopes of hantaviruses associated to hemorrhagic fever and renal syndrome
Published in PLoS neglected tropical diseases (01-12-2019)“…Orthohantavirus infection is a neglected global health problem affecting approximately 200,000 people/year, spread by rodent hosts and associated to fatal…”
Get full text
Journal Article -
10
Congenital Zika Syndrome Is Associated With Interferon Alfa Receptor 1
Published in Frontiers in immunology (25-11-2021)“…Host factors that influence Congenital Zika Syndrome (CZS) outcome remain elusive. Interferons have been reported as the main antiviral factor in Zika and…”
Get full text
Journal Article -
11
Different aspects of platelet evaluation in dengue: Measurement of circulating mediators, ability to interact with the virus, the degree of activation and quantification of intraplatelet protein content
Published in Virus research (15-01-2019)“…•CD62P, NO and TBX2 ratio in platelet count may be predictors of dengue outcome.•Platelets undergo morphological activation with increase of CD62P in…”
Get full text
Journal Article -
12
Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha
Published in Frontiers in cellular and infection microbiology (07-07-2021)“…Sustained virologic response (SVR) in chronic hepatitis C (CHC) treatment denotes that the host genetics controls the immune response and unequivocally…”
Get full text
Journal Article -
13
Unleashing Fungicidal Forces: Exploring the Synergistic Power of Amphotericin B-Loaded Nanoparticles and Monoclonal Antibodies
Published in Journal of fungi (Basel) (01-05-2024)“…Fungal infections cause 1.7 million deaths annually, which can be attributed not only to fungus-specific factors, such as antifungal resistance and biofilm…”
Get full text
Journal Article -
14
Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice
Published in Vaccines (Basel) (28-12-2022)“…The attenuated yellow fever (YF) vaccine is one of the most successful vaccines ever developed. After a single dose administration YF vaccine can induce…”
Get full text
Journal Article -
15
Correction: Recombinant Yellow Fever Viruses Elicit CD8+ T Cell Responses and Protective Immunity against Trypanosoma cruzi
Published in PloS one (2013)“…[This corrects the article DOI: 10.1371/journal.pone.0059347.]…”
Get full text
Journal Article -
16
The role of immune subtyping in glioma mRNA vaccine development
Published in Immunotherapy (01-09-2023)“…Studies on the development of mRNA vaccines for central nervous system tumors have used gene expression profiles, clinical data and RNA sequencing from sources…”
Get full text
Journal Article -
17
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
Published in Pharmaceuticals (Basel, Switzerland) (05-05-2022)“…The depth and versatility of siRNA technologies enable their use in disease targets that are undruggable by small molecules or that seek to achieve a refined…”
Get full text
Journal Article -
18
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs
Published in Journal of immunology research (2020)“…The severe acute respiratory syndrome caused by the new coronavirus (SARS-CoV-2), termed COVID-19, has been highlighted as the most important infectious…”
Get full text
Journal Article -
19
Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials
Published in Viruses (30-06-2023)“…Successful SARS-CoV-2 inactivation allows its safe use in Biosafety Level 2 facilities, and the use of the whole viral particle helps in the development of…”
Get full text
Journal Article -
20
Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.)
Published in Journal of medical primatology (01-02-2021)“…Background Alouatta spp. are highly susceptible to yellow fever (YF) infection and develop an often fatal disease. The threat posed by an outbreak started in…”
Get full text
Journal Article